Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sanders

Showing results (1181-1190 of 1,255) with videos related to

Pageof 126
Sort By:
Blood|May 10, 2007
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersChunkang Chang, Barry E Storer, Bart L Scott, et al.
Frontiers in Oncology|January 8, 2024
27-hydroxycholesterol and DNA damage repair: implication in prostate cancerGloria Cecilia Galvan, Nadine A Friedrich, Sanjay Das, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2012
A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24Kathryn S Higginbotham, Joan P Breyer, Kate M McReynolds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2008
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancersMarta Guix, Nara de Matos Granja, Ingrid Meszoely, et al.
Blood|August 5, 2004
Duration of immunosuppressive treatment for chronic graft-versus-host diseaseBetty L Stewart, Barry Storer, Jan Storek, et al.
Journal of the National Cancer Institute|October 24, 2017
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand OverexpressionLuis J Schwarz, Katherine E Hutchinson, Brent N Rexer, et al.
Journal of General Internal Medicine|June 17, 2025
Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh BenefitsEmily Brunner, Chwen-Yuen A Chen, Tracy Klein, et al.
Blood|January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaMary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
AIDS Research and Human Retroviruses|January 28, 2012
Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007Paul T Scott, Shilpa Hakre, Otha Myles, et al.
JAMA Oncology|December 14, 2023
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical TrialBrian D Lehmann, Vandana G Abramson, E Claire Dees, et al.
Pageof 126

Showing results (1181-1190 of 1,255) with videos related to

Sort By:
Pageof 126
Blood|May 10, 2007
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersChunkang Chang, Barry E Storer, Bart L Scott, et al.
Frontiers in Oncology|January 8, 2024
27-hydroxycholesterol and DNA damage repair: implication in prostate cancerGloria Cecilia Galvan, Nadine A Friedrich, Sanjay Das, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2012
A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24Kathryn S Higginbotham, Joan P Breyer, Kate M McReynolds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2008
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancersMarta Guix, Nara de Matos Granja, Ingrid Meszoely, et al.
Blood|August 5, 2004
Duration of immunosuppressive treatment for chronic graft-versus-host diseaseBetty L Stewart, Barry Storer, Jan Storek, et al.
Journal of the National Cancer Institute|October 24, 2017
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand OverexpressionLuis J Schwarz, Katherine E Hutchinson, Brent N Rexer, et al.
Journal of General Internal Medicine|June 17, 2025
Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh BenefitsEmily Brunner, Chwen-Yuen A Chen, Tracy Klein, et al.
Blood|January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaMary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
AIDS Research and Human Retroviruses|January 28, 2012
Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007Paul T Scott, Shilpa Hakre, Otha Myles, et al.
JAMA Oncology|December 14, 2023
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical TrialBrian D Lehmann, Vandana G Abramson, E Claire Dees, et al.
Pageof 126